ArticleChinese medicine2026
Systematic identification of characteristic chemical constituents in Cistanches Herba from saline-alkali land based on hierarchical filtering of mass spectrometry data and spatial metabolomics technology.
Article in Chinese medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
backgroundThe traditional habitat of the Chinese medicinal plant Cistanches Herba (CH) is the deserts of northwestern China. Recently, CH cultivation has been introduced to saline-alkali land (SAL) in the Yellow River delta region. However, the effects of this SAL environment on the accumulation of secondary metabolites in CH remain unclear.
objectiveThis research aims to systematically characterize the chemical profiles of CH grown in SAL and to identify key chemical markers associated with the SAL environment.
methodsCH samples were collected from both SAL and traditional sandy land (SL). Untargeted metabolomics was performed using ultra performance liquid chromatography-quadrupole time-of-flight mass spectrometry (UPLC-QTOF-MS) to characterize the global metabolic profiles of CH from two habitats. Chemical markers associated with SAL environments were screened via weighted gene co-expression network analysis (WGCNA), targeted quantification by ultra performance liquid chromatography-triple quadrupole mass spectrometry (UPLC-TQ-MS), and compound loading contributions of principal component analysis (PCA). Subsequently, desorption electrospray ionization mass spectrometry imaging (DESI-MSI) was employed to visualize the in situ spatial distribution of partial screened constituents in mouse organs.
resultsUntargeted UPLC-QTOF-MS metabolomics identified 74 chemical constituents from CH samples, including 40 phenylethanoid glycosides, 13 iridoid glycosides, 9 lignans, and other minor constituents. Orthogonal projections to latent structures-discriminant analysis (OPLS-DA) clearly separated the SAL and SL sample groups, with 30 constituents showing prominent contributions to the discrimination. WGCNA revealed 23 metabolites correlated with SAL. By integrating these two screening methods, 12 constituents were preliminarily selected as candidate markers associated with SAL. Subsequently, combining PCA loading coefficients (with the PCA model validated by Kaiser-Meyer-Olkin and Bartlett's sphericity tests) and targeted UPLC-TQ-MS quantification, 4 constituents-verbascoside, echinacoside, isoacteoside, and pinoresinol- were ultimately identified as characteristic chemical markers, all exhibiting significantly higher levels in SAL samples. DESI-MSI results further demonstrated that echinacoside predominantly accumulated in brain tissue, whereas verbascoside or isoacteoside displayed the strongest ion signal in the lung.
conclusionThis study developed an integrated strategy that combines hierarchical filtering of mass spectrometry data to successfully identify 4 characteristic chemical markers of CH associated with SAL. This strategy provides a scientific basis for future quality control and resource development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.